Metabolomics in Clinical Drug DevelopmentWednesday, 14 March 2012 at 09:30 Add to Calendar ▼2012-03-14 09:30:002012-03-14 10:30:00Europe/LondonMetabolomics in Clinical Drug DevelopmentADME and Predictive Toxicology Europe in Munich, GermanyMunich, GermanySELECTBIOenquiries@selectbiosciences.com High throughput metabolomics can be used to identify biomarkers in serum or urine that can stratify populations during clinical trials. This could lead to greater success in drug development by predicting individuals susceptible to adverse drug reactions and drug efficacy. |